DarioHealth Corp. Overview
Pro stress-test →DarioHealth is a leader in the global digital health market, offering a hyper-personalized whole-person solution covering multiple conditions including diabetes, hypertension, weight management, musculoskeletal, and behavioral health within one integrated, AI-powered technology platform. With over 100 peer-reviewed scientific studies, Dario offers measurable clinical improvement and a value-based pricing model with an attractive ROI of up to 5x for payers including employers and insurers.
Strategic Profile
Pro stress-test →In Q1 2026, DarioHealth achieved its second consecutive quarter of sequential revenue growth alongside continued reductions in operating expenses. The company's channel partner ecosystem now provides access to more than 116 million covered lives through blue-chip partners such as Solera and Amwell, expanding reach into leading national and regional payer organizations across the U.S.
Competitive Landscape
Pro stress-test →Competitors include Apree Health, Blue Mesa Health, FiNC Technologies, Wildflower Health, and MySugr. Dario's multi-condition platform covering 6+ conditions differentiates it as more comprehensive than other digital health competitors. The company serves a blue-chip customer base spanning over 160 clients including Fortune 100 employers and national health plans.
Industry Context
DarioHealth Corp. operates in Digital therapeutics for chronic conditions.
Key facts
Founded: 2011 · Headquarters: New York, US · Employees: 196 · Revenue: $22.4M · Market cap: $56.9M